The UK Government has announced its support of new research that will help support those living with dementia, a condition that can severely impact memory, communication, and daily living.
Dr. Gerardo Fernandez, CSO ViewMind Inc, investigates how early is too early for the detection of Alzheimer’s disease and how soon in the disease’s trajectory detection can make a meaningful difference in a patient’s prognosis.
After decades of failure for Alzheimer’s researchers, Lecanemab could open the door to a new ear of drugs to treat Alzheimer’s disease – the world's most common form of dementia.
Including cranberries in your diet has a whole host of benefits - it can improve memory and brain function, lower ‘bad’ cholesterol and prevent dementia.
Is better diagnosis the key to unlocking life-changing dementia treatments? Dr Susan Mitchell, Head of Policy at Alzheimer’s Research UK provides the answer.
To improve understanding of the impact and epidemiology of Alzheimer’s disease, Project Alzheimer’s Value Europe (PAVE) demonstrates the prevalence of Alzheimer’s across the stages of the disease, including prodromal and preclinical – which aren’t recognised by previous studies.
Getting lost can affect caregivers and families of older people with dementia – now, a Bluetooth tracking device can assist the search for their loved ones.
According to new results in the Journal of Alzheimer’s Disease, patients who start abusing alcohol in later life – after age 40 – maybe doing so due to underlying dementia
Dr Lynn Woods, Professor in the Department of Doctoral Programs, School of Nursing, Azusa Pacific University, provides further analysis of Latinx developing dementia, including systems of healing & the challenge of behavioural symptoms.
Professor Timothy Kwok, Director of the Jockey Club Centre for Positive Ageing, and Research Manager Ms Bel Wong, explain the necessity of dementia day care services during the pandemic.
The healthier pre-industrial lifestyles which Indigenous communities live by present solutions in preventing Alzheimer’s and dementia – as seen in their lower rates of the disease.
